Market Place
Sourcing Support
WuXi STA Adds New Peptide Manufacturing Capacity
05 Apr 2023 //
CONTRACT PHARMA
Pasithea Signs CMC Development and Manufacturing Agreement
26 Jan 2023 //
CONTRACT PHARMA
WuXi STA Launches First Continuous Manufacturing Line for Oral Solids
05 Jan 2023 //
CONTRACT PHARMA
WuXi STA sites receive top EcoVadis scores for business sustainability rating
17 Dec 2022 //
PHARMABIZ
WuXi STA and Multiply Labs Announce Partnership
01 Dec 2022 //
BUSINESSWIRE
WuXi STA Launches New Parenteral Formulation Manufacturing Line
30 Nov 2022 //
CONTRACTPHARMA
Aceto rebrands to Actylis; WuXi STA opens another facility
29 Sep 2022 //
ENDPTS
WuXi STA Opens High Potency Oral Drug Product Manufacturing Facility
27 Sep 2022 //
CONTRACTPHARMA
WuXi STA Opens First High Potency Oral Drug Product Manufacturing Facility
26 Sep 2022 //
PRNEWSWIRE
WuXi STA Opens New Sterile Lipid Nanoparticle Formulation Facility
12 Sep 2022 //
CONTRACTPHARMA
Qualigen Engages STA Pharmaceutical as GMP Manufacturer of AS1411
05 Nov 2020 //
PRNEWSWIRE
Onconova, STA Ink Exclusive License Agreement
18 Dec 2019 //
CONTRACT PHARMA
WuXi STA Announces Successful EMA Inspection of Jinshan Facility
30 Oct 2019 //
PHARMATECH
STA To Market Sarcoma Drug In Australia, New Zealand And SE Asia
14 Oct 2019 //
BIOSPACE
STA Pharma passes two US FDA inspections
24 Jul 2019 //
THE PHARMALETTER
WuXi STA Facilities Pass FDA Inspections
23 Jul 2019 //
CONTRACT PHARMA
WuXi STA`s New Drug Product Mfg Facility Passes First EU MPA GMP Inspection
27 Mar 2019 //
PRASIA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.